Last update 23 Jan 2025

IL-13Rα2 x Tubulin

Basic Info

Related Targets
IL-13Rα2Tubulin

Related

1
Drugs associated with IL-13Rα2 x Tubulin
LM-306
Target
IL-13Rα2 x Tubulin
Mechanism
IL-13Rα2 inhibitors [+1]
Active Org.
Shanghai LaNova Medicines Research and Development Co Ltd
Originator Org.
LaNova Medicines Ltd.LaNova Medicines Ltd.
Active Indication
Neoplasms
Inactive Indication
Solid tumor
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with IL-13Rα2 x Tubulin
Login to view more data
100 Translational Medicine associated with IL-13Rα2 x Tubulin
Login to view more data
0 Patents (Medical) associated with IL-13Rα2 x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free